What is the BLUE (Bedside Lung Ultrasound in Emergency) protocol for performing lung point‑of‑care ultrasound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

BLUE Protocol for Lung Point-of-Care Ultrasound

The BLUE (Bedside Lung Ultrasound in Emergency) protocol is a rapid, systematic ultrasound examination that evaluates three anterior chest points bilaterally plus lateral points to diagnose the cause of acute respiratory failure in under 3 minutes, achieving >90% diagnostic accuracy for differentiating between pulmonary edema, pneumonia, COPD/asthma, pulmonary embolism, and pneumothorax. 1, 2

Core Technique and Scanning Points

The protocol uses a microconvex probe to examine standardized chest locations 1:

  • Three anterior points per hemithorax: Upper and lower BLUE points along the midclavicular line
  • Posterolateral alveolar and/or pleural syndrome (PLAPS) point: Evaluated when anterior findings are inconclusive
  • Venous analysis: Compression ultrasound of femoral veins when pulmonary embolism is suspected

Essential Ultrasound Signs (10 Key Findings)

You must recognize these artifacts to interpret the protocol 1, 2:

Normal lung surface:

  • Bat sign: Two ribs with acoustic shadow and pleural line between them
  • Lung sliding: Shimmering movement of pleural line with respiration (produces "seashore sign" on M-mode)
  • A-lines: Horizontal repetitive artifacts parallel to pleural line

Pathological findings:

  • B-lines (lung rockets): Vertical laser-like artifacts extending from pleura to screen edge, indicating interstitial syndrome
  • Lung consolidation: Tissue-like appearance (fractal sign) replacing normal aeration
  • Pleural effusion: Anechoic space between parietal and visceral pleura (quad sign, sinusoid sign)
  • Pneumothorax indicators: Absent lung sliding with A-lines (stratosphere sign on M-mode) and lung point (transition between sliding and non-sliding lung—pathognomonic for pneumothorax)

Diagnostic Profiles and Their Meanings

The protocol assigns specific profiles based on bilateral anterior findings 1, 3:

A Profile (Predominant A-lines + lung sliding bilaterally)

  • Diagnosis: COPD or asthma
  • Accuracy: 85% sensitivity, 89% specificity 3
  • Caveat: If venous thrombosis detected → pulmonary embolism instead

A' Profile (A-lines WITHOUT lung sliding)

  • Diagnosis: Pneumothorax (confirm with lung point)
  • Accuracy: 80-100% sensitivity, 100% specificity 3

B Profile (Bilateral anterior B-lines/lung rockets + lung sliding)

  • Diagnosis: Cardiogenic pulmonary edema
  • Accuracy: 92% sensitivity, 100% specificity 3
  • Mechanism: B-lines correlate with pulmonary artery occlusion pressure >18 mmHg 1

A/B Profile (A-lines on one side, B-lines on other)

  • Diagnosis: Pneumonia
  • Confirm with: PLAPS point showing consolidation or effusion posterolaterally
  • Accuracy: 94% sensitivity, 94% specificity 3

C Profile (Anterior lung consolidation)

  • Diagnosis: Pneumonia
  • Distinguish from atelectasis: Look for dynamic air bronchogram (rules in pneumonia) vs. lung pulse (suggests atelectasis) 2

Clinical Integration and Workflow

When to use: Any patient presenting with acute dyspnea or respiratory distress 4

Advantages over standard workup:

  • POCUS added to standard diagnostic pathways significantly increases correct diagnoses compared to clinical examination alone 4
  • No radiation exposure (critical for repeated assessments and pediatric/neonatal patients) 5
  • Performed in real-time by treating clinician, enabling immediate management decisions 4

Performance characteristics: The BLUE protocol demonstrates diagnostic accuracy equivalent to CT scanning for acute respiratory failure 3, with sensitivities and specificities consistently >90% for major causes of dyspnea 5

Critical Pitfalls to Avoid

  1. Subcutaneous emphysema or large body habitus: May obscure lung sliding—do not diagnose pneumothorax on absent sliding alone; always seek the lung point 1

  2. Pneumonia vs. atelectasis confusion: Both show consolidation, but pneumonia has dynamic air bronchogram (moving with respiration), while atelectasis shows lung pulse (cardiac oscillations transmitted through airless lung) 2

  3. Focal vs. diffuse B-lines: Focal B-lines suggest pneumonia; diffuse bilateral B-lines indicate pulmonary edema 5

  4. Consolidations not reaching pleura: Lung ultrasound cannot detect central lung pathology that doesn't contact the pleural surface 5, 6

  5. Indeterminate results: Studies rarely report the proportion of inconclusive scans—when findings don't fit a clear profile, proceed to CT imaging 4

Monitoring and Therapeutic Applications

Beyond diagnosis, the BLUE protocol enables real-time monitoring 5:

  • Quantify pulmonary edema severity: Count total B-lines (28-point technique) or number of positive scanning sites (8-region technique) 5
  • Track treatment response: Decreasing B-lines indicate successful diuresis in heart failure 5
  • Guide fluid resuscitation: In the FALLS protocol (Fluid Administration Limited by Lung Sonography), appearance of B-lines serves as endpoint for fluid therapy, preventing iatrogenic pulmonary edema 1, 2

Evidence Quality Considerations

The 2021 American College of Physicians guideline 4 found that while POCUS improves diagnostic accuracy, in-hospital mortality and length of stay did not differ significantly between patients who did or did not receive POCUS—likely because the studies assessed diagnostic accuracy rather than patient-centered outcomes. However, the 2012 international consensus recommendations [5-5] provide strong Level A evidence supporting lung ultrasound for detecting consolidation, differentiating causes of dyspnea, and monitoring therapy response.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.